9 results within Condition Category: Haematological Disorders Remove filter Countries of recruitment: France Remove filter

• ISRCTN50040185 : NuProtect: Immunogenicity, efficacy and safety of treatment with Human-cl rhFVIII in previously untreated patients with severe haemophilia A

  Overall trial status

  Ongoing

  Recruitment status

  No longer recruiting

  France

  Haematological Disorders

  Date assigned

  22/10/2013

• ISRCTN37539930 : Clinical study to evaluate the efficacy and safety of immunoglobulin intravenous (human) 10% (NewGam) in Primary Immune Thrombocytopenia

  Overall trial status

  Completed

  Recruitment status

  No longer recruiting

  France

  Haematological Disorders

  Date assigned

  27/02/2013

• ISRCTN99606748 : Clinical study in which the long term effect of Human-cl rhFVIII is investigated in children with severe haemophilia A, who were previously treated in the GENA-03 study

  Overall trial status

  Completed

  Recruitment status

  No longer recruiting

  France

  Haematological Disorders

  Date assigned

  03/01/2012

• ISRCTN02245668 : The tolerability of Octagam® 5% and Octagam® 10%

  Overall trial status

  Completed

  Recruitment status

  No longer recruiting

  France

  Haematological Disorders

  Date assigned

  25/10/2011

• ISRCTN30718752 : Gene therapy for Wiskott-Aldrich Syndrome (WAS)

  Overall trial status

  Completed

  Recruitment status

  No longer recruiting

  France

  Haematological Disorders

  Date assigned

  20/05/2011

• ISRCTN71212110 : Prospective clinical study in children with severe haemophilia A to investigate clinical efficacy, immunogenicity, pharmacokinetics, and safety of Human-cl rhFVIII

  Overall trial status

  Completed

  Recruitment status

  No longer recruiting

  France

  Haematological Disorders

  Date assigned

  23/02/2011

• ISRCTN41980964 : A Randomized Controlled Study in Newly Diagnosed Severe Aplastic Anemia Patients Receiving Antithymocyte Globulin (ATG), Cyclosporin A, with or without Granulocyte Colony Stimulating Factor (G-CSF)

  Overall trial status

  Completed

  Recruitment status

  No longer recruiting

  France

  Haematological Disorders

  Date assigned

  21/10/2005

• ISRCTN05896089 : A randomised, multicentre, open label, phase Il study to evaluate the safety, tolerability, pharmacokinetics and the effects on liver iron concentration of repeated doses of 10 mg/kg/day of ICL670 relative to deferoxamine in sickle cell disease (SCD) patients with transfusional haemosiderosis

  Overall trial status

  Completed

  Recruitment status

  No longer recruiting

  France

  Haematological Disorders

  Date assigned

  05/09/2003

• ISRCTN93355192 : A randomised, comparative, open label phase III trial on efficacy and safety of long-term treatment with ICL670 (5 to 40 mg/kg/day) in comparison with deferoxamine (DFO) (20 to 60 mg/kg/day) in β-thalassaemia patients with transfusional haemosiderosis

  Overall trial status

  Completed

  Recruitment status

  No longer recruiting

  France

  Haematological Disorders

  Date assigned

  05/09/2003